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Abstract
Background:  Laparoscopic  sleeve  gastrectomy  is  a  surgical  procedure  for  the  treatment  of  mor-
bid obesity.  However,  there  are  still  controversies  regarding  its  efﬁciency  in  terms  of  weight
reduction  and  incidence  of  complications.  In  this  prospective  study,  the  experience  is  presented
of a  referral  centre  for  the  treatment  of  morbid  obesity  with  laparoscopic  sleeve  gastrectomy.
Material  and  methods:  A  prospective  study  on  73  patients  subjected  to  laparoscopic  sleeve
gastrectomy  from  February  2009  to  September  2013.  Patients  were  followed-up  for  a  period
of 12  months,  evaluating  the  development  of  complications,  reduction  of  gastric  volume,  and
the weight  loss  associated  with  the  surgery,  as  well  as  their  impact  on  the  improvement  of
comorbidities  present  at  beginning  of  the  study.
Results:  There  was  a  statistically  a  signiﬁcantly  reduction  between  the  preoperative  body  mass
index (BMI)  and  the  BMI  at  12  months  after  laparoscopic  sleeve  gastrectomy  (p  <  0.001),  despite
there being  an  increase  in  the  gastric  volume  during  follow-up,  measured  at  one  month  and  12
months after  surgery  (p  <  0.001).  Five  patients  (6.85%)  had  complications,  with  none  of  them
serious and  with  no  deaths  in  the  whole  series.
Conclusions:  Laparoscopic  sleeve  gastrectomy  is  a  safe  and  effective  technique  for  the  treat-
ment of  morbid  obesity.  Its  use  is  associated  with  a  signiﬁcant  reduction  in  the  presence  of
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comorbidities  associated  with  obesity.  Multicentre  studies  with  a  longer  period  of  monitoring
are required  to  conﬁrm  the  efﬁcacy  and  safety  of  this  surgical  technique.
© 2015  Academia  Mexicana  de  Cirug´ıa  A.C.  Published  by  Masson  Doyma  Me´xico  S.A.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Resultados,  controversias,  y  volumen  gástrico  después  de  la  gastrectomía  vertical
laparoscópica  en  el  tratamiento  de  la  obesidad
Resumen
Antecedentes:  La  gastrectomía  vertical  laparoscópica  es  una  intervención  quirúrgica  para  el
tratamiento  de  la  obesidad  mórbida.  Existen  controversias  respecto  a  su  eﬁciencia  en  términos
de reducción  de  peso  e  incidencia  de  complicaciones.  En  este  estudio  prospectivo,  presenta-
mos la  experiencia  en  un  centro  de  referencia  en  el  tratamiento  de  la  obesidad  mórbida  con
gastrectomía  vertical  laparoscópica.
Material  y  métodos:  Estudio  prospectivo  con  73  pacientes  tratados  mediante  gastrectomía  ver-
tical laparoscópica,  desde  febrero  de  2009  hasta  septiembre  de  2013.  Los  pacientes  fueron
seguidos  durante  un  periodo  de  12  meses.  Se  evaluaron:  el  desarrollo  de  complicaciones,  la
reducción  del  volumen  gástrico,  y  la  pérdida  ponderal  asociada  a  la  intervención;  así  como  su
impacto en  la  mejora  de  las  comorbilidades  presentes  al  inicio  del  estudio.
Resultados:  Se  observó  una  signiﬁcativa  reducción  entre  el  índice  de  masa  corporal  (IMC)  preop-
eratorio y  el  IMC  a  los  12  meses  tras  la  gastrectomía  vertical  laparoscópica  (±DE  p  <  0.001);  ello
pese a  que  los  pacientes  experimentaron  un  incremento  en  el  volumen  de  la  cavidad  gástrica,
medido  al  mes  y  a  los  12  meses  tras  la  intervención  (±DE  p  <  0.001).  Cinco  pacientes  (6.85%)
presentaron  complicaciones,  ninguna  de  ellas  graves.  No  hubo  muertes  en  la  totalidad  de  la
serie.
Conclusiones:  La  gastrectomía  vertical  laparoscópica  es  una  técnica  segura  y  eﬁcaz  para  el
tratamiento  de  la  obesidad  mórbida,  su  uso  se  asocia  a  una  importante  reducción  en  la  presencia
de comorbilidades  asociadas  a  la  obesidad.  Son  necesarios  estudios  multicéntricos,  con  un  mayor
periodo de  seguimiento,  que  conﬁrmen  la  eﬁcacia  y  seguridad  de  esta  técnica  quirúrgica.
© 2015  Academia  Mexicana  de  Cirug´ıa  A.C.  Publicado  por  Masson  Doyma  Me´xico  S.A.  Este  es  un
art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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aparoscopic  sleeve  gastrectomy  is  a  surgical  procedure  that
s  being  increasingly  used  worldwide  to  treat  morbid  obesity.
t  is  a  restrictive  technique  which  is  effective,  it  seems,
ot  only  in  reducing  gastric  volume  thus  inducing  acceler-
ted  satiation  but  neurohumoral  mechanisms  might  also  be
nvolved,  since  a  reduction  in  levels  of  ghrelin,  the  appetite
timulating  hormone,  is  also  observed.1,2
This  technique  is  the  restrictive  part  which  complements
ther  procedures,  known  as  mixed  techniques;  we  refer  to
he  duodenal  switch,  where  a  biliopancreatic  diversion  is
lso  performed.  Hess  and  Hess  performed  the  ﬁrst  duode-
al  switch  in  1988.3 Almogy  et  al.4 had  been  performing
ubular  gastrectomy  via  the  open  approach  since  1993,  in
rder  to  reduce  the  risk  of  superobese  (BMI  above  55),
ale  patients  aged  over  55.  In  1999,  Gagner  and  Patterson5
ompleted  the  ﬁrst  laparoscopic  sleeve  gastrectomy  in  New
ork’s  Mount  Sinai  Hospital,  as  part  of  a  duodenal  switch.  A
ew  years  later,  Regan  et  al.6 proposed  laparascopic  sleeve
astrectomy  as  the  ﬁrst  step  of  gastric  bypass,  as  a  treat-
s
o
ient  alternative  for  high-risk  obese  patients,  with  a  view  to
educing  morbidity  and  mortality.
Since  then  many  surgical  teams  have  adopted  this  tech-
ique,  with  good  outcomes,  although  the  indications  for  it
emain  uncertain.  Some  institutions  maintain  that  laparo-
copic  sleeve  gastrectomy  should  be  the  ﬁrst  step  in  high-risk
atients  and  patients  with  a  high  body  mass  index  (BMI);  the
dea  being  to  perform  a  second  deﬁnitive  operation  after
cceptable  weight  loss  has  been  achieved  in  order  to  reduce
urgical  risk.  By  contrast,  other  teams  consider  it  an  alter-
ative  to  the  adjustable  gastric  band,  to  gastric  bypass  or
o  biopancreatic  diversion  with  duodenal  switch.7,8
The  fact  that  this  technique  has  erroneously  been  consid-
red  simple  and  easily  reproducible  has  encouraged  a  great
any  surgeons  to  perform  it.  It  could  seem  that,  compared
o  gastric  bypass  and  biopancreatic  derivation,  it  is  more
 manageable  operation  from  a  laparoscopic  perspective.
owever,  we  should  remain  aware  that  its  complications,
uch  as  the  onset  of  gastric  ﬁstulae,  can  be  very  seri-
us  and  most  authors  agree  that  a  long  learning  curve
s  necessary.9--12 Although  a low  percentage  appear,  these
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Figure  1  Inclusion  circuit.
tion  
s
t
T
t
4
p
n
F
A
a
3
c
s
a
r
d
g
s
a
considered  when  there  was  an  LDL  cholesterol  level  of
below  160  mg/dl,  and  triglycerides  <200  mg/dl;  remission  of
severe  osteoarthritis  was  considered  as  a  response  to  the
withdrawal  of  pain  relief  medication  and  the  absence  ofIf the  patients  had  gained  5%  or  more  weight  prior  to  the  opera
PC: primary  care.
complications  increase  morbidity,  hospital  stay  and  place
the  life  of  the  patient  at  risk.
In  light  of  the  above,  we  prospectively  evaluated  a  series
of  patients  who  underwent  laparascopic  sleeve  gastrectomy
in  our  centre  for  the  treatment  of  morbid  obesity.
Material and methods
This  was  an  observational  prospective  study  which  included
patients  operated  consecutively  between  2  February  2009
and  26  September  2013.  All  the  patients  were  operated  by
the  bariatric  surgery  team  of  the  Complejo  Hospitalario  Tor-
recárdenas  of  Almeria  (Spain),  which  comprises  3  surgeons
and  a  multidisciplinary  team  of  endocrinologists,  nutrition-
ists  and  psychologists.  The  patients  who  were  candidates  for
surgery  had  a  BMI  ≥40  kg/m2,  or  BMI  ≥35  kg/m2 and  also  at
least  one  of  the  following  comorbidities:  diabetes  mellitus,
high  blood  pressure,  dyslipidaemia,  severe  osteoarthritis,
obstructive  sleep  apnoea  syndrome  and  hypoventilation-
obesity  syndrome.  In  addition  to  their  BMI,  the  patients  who
were  candidates  for  the  operation  had  to  meet  the  following
criteria:  (a)  be  aged  between  18  and  60  years;  (b)  have  been
obese  for  more  than  5  years;  (c)  other  treatments  had  failed
for  them;  (d)  have  an  acceptable  surgical  risk;  (e)  be  cer-
tain  to  cooperate  during  follow-up,  and  (f)  have  signed  their
informed  consent.  The  patients  who  fulﬁlled  these  crite-
ria  were  assessed  by  a  multidisciplinary  team  as  shown  in
Fig.  1.  Once  the  operation  had  been  indicated,  the  patients
were  evaluated  by  the  bariatric  committee  and  assigned  a
scale  to  be  put  on  the  waiting  list  for  surgery.  The  patients
were  admitted  the  day  before  surgery  to  undergo  a com-
plete  assessment  of  their  physical  and  mental  parameters
and  preoperative  laboratory  tests.
Surgical  technique
The  operation  started  with  the  supraumbilical  insertion  of
an  optical  trocar  and  placement  of  4  accessory  trocars
(12  mm).  The  greater  gastric  curvature  was  dissected  using
Ligasure,  starting  at  about  4  cm  from  the  pylorus,  up  to  the
angle  of  Hiss.  Adherences  on  the  posterior  gastric  face  were
released.  A  34-F  Faucher’s  tube  was  inserted  before  per-
forming  the  gastric  section.  The  section  was  performed  using
an  endocutter  and  then  reinforced  with  invaginating  suture
with  2-0  absorbable  monoﬁlament  suture  (Fig.  2).  Methy-
lene  blue  solution  was  used  to  test  for  leaks,  a  surgical
F
sthey  were  excluded.
pecimen  was  taken  and  a  suction  drain  left.  Nasogastric
ubes  or  bladder  catheters  were  not  used  in  the  operation.
he  patients  were  mobilised  the  evening  after  surgery  and
he  next  day.  A  methylene  blue  test  for  leaks  was  performed
8  h  after  surgery  and  if  negative,  ﬂuids  were  given.  The
atients  were  discharged  72  h  after  surgery  if  there  had  been
o  incidents.
ollow-up
ll  the  patients  were  kept  on  a  semi-liquid  diet  for  4  weeks
fter  the  operation  and  then  assessed  as  outpatients  at  1,
,  6,  and  12  months  after  surgery.  All  the  patients  were  also
losely  monitored  by  the  Nutrition  Department.
The  comorbidities  mentioned  in  the  preoperative  inclu-
ion  criteria  were  assessed  at  12  months  after  surgery
nd  were  deﬁned  as  present  or  in  remission  as  follows:
emission  of  diabetes  mellitus  was  deﬁned  as  antidiabetic
rugs  discontinued  by  the  endocrinologist,  HBA1c  ≤6.5%  and
lycaemia  below  126  mg/dl;  remission  of  high  blood  pres-
ure  as  blood  pressure  ≤140/90  mmHg  with  withdrawal  of
ntihypertensive  drugs;  remission  of  hyperlipidaemia  wasigure  2  Reinforcement  of  the  staple  line  by  invaginating
uture.
3 J.J.  García-Díaz  et  al.
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Table  2  Comparison  of  BMI  weights  and  initial  gastric  tube
volumes  and  at  12  months.
Mean  p
Initial  BMI  50.18  kg/m2 <0.001*
BMI  at  12  months 33.48  kg/m2
Transit  at  one  month  69.46  cm3 <0.001**
Transit  at  12  months  117.58  cm3
*
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ssociated  symptoms;  remission  of  obstructive  sleep  apnoea
yndrome  as  discontinued  use  of  the  continuous  positive  air-
ay  pressure  mask,  and  remission  of  hypoventilation-obesity
yndrome  as  the  absence  of  daytime  hypersomnia  and  car-
iorespiratory  symptoms.  Remission  of  the  latter  2  disorders
as  conﬁrmed  by  polysomnography.
A  barium  study  of  upper  gastrointestinal  transit  was  per-
ormed  on  all  the  patients  at  one  month  and  at  12  months
fter  the  operation,  except  those  presenting  ﬁstulae,  who
nderwent  gastrograﬁn  study  to  assess  the  measurements
nd  characteristics  of  the  gastric  sleeve.  In  this  case,  the
eneral  volume  of  the  gastric  sleeve  (V)  was  equivalent  to
 =  r2h  (in  cm3),  where  h  =  height  and  r  =  the  radius  in  cm.
tatistical  analysis
he  continuous  variables  were  expressed  as
eans±standard  deviations  or  range.  Comparisons  between
 continuous  variables  were  made  using  the  Student’s
-test  or  Wilcoxon’s  test  for  normalised  or  unnormalised
ariables,  respectively.  Similarly,  comparison  between  more
han  2  continuous  variables  was  made  using  the  Anova  or
ruskal--Wallis  test,  according  to  whether  the  distribution
as  normal  or  not.  Comparison  between  preoperative  and
ostoperative  ordinal  variables  was  made  using  McNemar’s
est  or  the  2 test  and  Fisher’s  exact  test  where  necessary.
he  statistical  package  SPSS  version  22.0  for  Windows  was
sed  for  the  analysis.
esults
 total  of  73  patients  were  operated  between  February  2009
nd  August  2013.  These  patients’  preoperative  characteris-
ics  are  shown  in  Table  1.
The  majority  were  female  with  a  mean  age  of  41.28
20--60)  years  (mean  [range]),  a  mean  weight  of  138.68
78--193)  kg  and  a  mean  BMI  of  50.54  (35.13--66.22)  kg/m2.
n  terms  of  comorbidities,  the  majority  presented  sleep  dis-
rders  (90.4%  hypoventilation-obesity  syndrome  and  56.2%
Table  1  Patient  characteristics  (preoperative  data).
n  =  70  100%
Age  (mean-range)  41.28  (20--60)
BMI (kg/m2)  50.54  (35.13--66.22)
Weight  (kg)  138.68  (78--193)
Sex
Female  52  71.2
Male 21  28.8
Comorbidities
DM 23  31.5
HBP 40  54.8
Dyslipidaemia  18  27.7
OSAS 41  56.2
HOS 66  90.4
Osteoarthritis  16  21.9
DM: diabetes mellitus; HBP: high blood pressure; OSAS: obstruc-
tive sleep apnoea syndrome; HOS: hypoventilation-obesity
syndrome.
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ﬁp value obtained by the Student’s t-test.
** p value obtained by Wilcoxon’s test.
bstructive  sleep  apnoea),  54.8%  were  hypertensive,  31.5%
ad  type  2  diabetes,  24.7%  had  dyslipidaemia  and  21.9%
steoarthritis.  None  of  the  patients  had  previously  under-
one  bariatric  surgery.
All  the  patients  had  a  signiﬁcant  reduction  in
ean  BMI  after  laparoscopic  sleeve  gastrectomy  at  12
onths,  compared  with  their  preoperative  measure-
ents  (33.5±6.2  kg/m2 and  50.2±6.9  kg/m2 respectively;
 < 0.001)  (Table  2).
Furthermore,  the  reduction  in  BMI  following  surgery  was
ot  affected  by  the  learning  curve,  since  when  the  series
as  divided  into  3  groups  according  to  the  time  of  the
peration,  the  ﬁrst  25  patients  operated  in  the  ﬁrst  year
ince  starting  the  technique  achieved  a  reduction  in  their
MI  which  was  similar  to  the  following  25  operated  in  the
econd  year  and  also  similar  to  the  last  23  patients  of  the
eries  operated  in  the  third  and  fourth  years  (15.9±5.5;
6.8±6.5  and  17.5±5.8,  respectively;  p  = 0.7).  The  percent-
ge  of  weight  loss  was  61.19%,  and  the  percentage  of  excess
MI  lost  was  67.92%;  and  neither  were  these  affected  by
he  learning  curve.  The  effect  on  weight  loss  associated
ith  laparoscopic  sleeve  gastrectomy  was  maintained  during
ollow-up,  despite  that  fact  that  the  patients  experienced  a
igniﬁcant  increase  in  gastric  cavity  volume,  established  by
astroduodenal  study,  which  showed  an  increase  from  69.46
18.8--196.3)  cm3 at  one  month  after  surgery,  to  117.58
25.13--274.88)  cm3 at  12  months  (p  <  0.001)  (Table  2).
Remission  of  diabetes  mellitus  occurred  in  83%  of  the
re-existing  cases,  hypertension  in  70%,  osteoarthritis  and
yslipidaemia  in  86  and  94%,  respectively,  while  obstruc-
ive  sleep  apnoea  and  hypoventilation-obesity  syndrome
emitted  in  all  of  the  patients.  These  differences  between
he  preoperative  data  and  at  12  months  were  signiﬁcant
Table  3).
The  complications  in  the  postoperative  period  were
 ﬁstulae  (4.1%),  one  total  stenosis  (1.4%)  and  one
ase  of  postoperative  bleeding  (1.4%)  with  no  signs  of
aemodynamic  repercussions.  The  3  ﬁstulae  were  diagnosed
uring  outpatient  follow-up  by  the  clinical  symptoms  and
maging  tests  (computed  tomography)  (Fig.  3).  All  were
esolved  satisfactorily,  one  with  conservative  treatment  and
he  placement  of  an  endoprosthesis  and  the  other  2  with
urgical  treatment  after  failed  attempts  to  place  an  endo-
rosthesis;  one  underwent  a  simple  laparoscopic  closure  and
he  other  was  reconverted  to  gastric  bypass.  The  steno-
is  required  conversion  to  gastric  bypass.  The  bleeding  was
esolved  by  surgical  review  and  haemostasis  of  the  short
lood  vessels.  All  the  complications  presented  during  the
rst  25  interventions  of  the  learning  curve.  The  73  patients
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Table  3  Comparison  of  obesity-associated  diseases  12  months  after  the  intervention.
Preintervention  Postintervention
Comorbidities  Presented  disease  after
the intervention
Did  not  present  disease
after  the  intervention
n  %  n  %  n  %  p
DM  23  31.5  4  5.5  69  94.5  <0.001
HBP 40  54.8  12  16.4  61  83.6  <0.001
Dyslipidaemia  18  27.7 1  1.4  72  98.6  <0.001
OSAS 41  56.2 0  0  73  100
HOS 66  90.4 0  0  73  100
Osteoarthritis  16  21.9  2  2.7  71  97.3  <0.001
DM: diabetes mellitus; HBP: high blood pressure; OSAS: obstructive sle
p value obtained by McNemar’s test and Fisher’s exact test.
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used  them  in  our  group  (48  patients).Figure  3  Abdominal  CAT  with  a  large  perigastric  collection
and left  pleural  effusion  secondary  to  gastric  ﬁstula.
completed  the  12-months’  follow-up  and  none  of  them  died
throughout  this  entire  period.
Discussion
Laparoscopic  surgery  has  represented  such  surgical  progress
over  recent  years  that  it  is  difﬁcult  to  imagine  this  operation
performed  without  the  use  of  minimally  invasive  techniques.
The  ﬁrst  laparoscopic  sleeve  gastrectomy  was  performed  by
Gagner  and  Patterson5 as  part  of  a  duodenal  switch.  How-
ever,  in  recent  years  this  operation  has  become  established
as  single  treatment  for  morbid  obesity,  due  to  its  good  out-
comes  and  the  low  incidence  of  complications  in  comparison
with  other  surgical  techiques.7,8
To  complete  their  training  bariatric  surgeons  require
advanced  training  in  laparoscopic  surgery.9 Despite  the  fact
that  laparoscopic  sleeve  gastrectomy  is  considered  by  some
to  be  a  simple  technique,  we  should  remember  that  its
complications  can  endanger  the  life  of  the  patient,  and  are
generally  more  difﬁcult  to  resolve  than  those  that  appear
after  the  mixed  techniques.  Some  authors  consider  that
there  is  a  long  learning  curve  (more  than  100  cases)  during
which  the  intra-  and  postoperative  morbidity  is  higher.10--12Due  to  the  inherent  conditions  of  the  patient  and  the
difﬁculty  of  the  surgical  technique,  there  are  2  ﬁelds  of
learning  required  for  laparoscopic  surgery:  ﬁrst, it  is  neces-
sary  to  have  experience  in  the  treatment  of  obese  patients,
w
Hep apnoea syndrome; HOS: hypoventilation-obesity syndrome.
nd  second, it  is  essential  to  have  experience  in  advanced
econstructive  laparoscopic  surgery  techniques.13
One  of  the  complications  that  bariatric  surgeons  most
ear  after  laparoscopic  sleeve  gastrectomy  is  the  appear-
nce  of  a  ﬁstula  in  the  proximal  third,  both  due  to  the
orbidity  it  involves  and  the  difﬁculty  in  resolving  it.  The
ncidence  of  ﬁstula  after  this  surgery  varies  between  0  and
%.14--16 Baker  et  al.17 argue  that  there  are  many  causes  of
stulae  on  the  staple  line,  but  these  can  be  placed  into
 categories:  mechanical/tissue  and  ischaemic  causes.  In
oth,  the  intraluminal  pressure  exceeds  the  resistance  of
he  tissue  and  the  suture  line,  giving  rise  to  the  ﬁstula.
raditional  ischaemic  ﬁstulae  usually  appear  between  the
th  and  6th  postoperative  day,  when  the  healing  process
f  the  wall  is  between  the  inﬂammation  stage  and  ﬁbrosis.
hen  the  cause  is  mechanical/tissue,  it  is  usually  discov-
red  earlier,  in  the  ﬁrst  2  days  after  surgery.  This  supports
he  use  of  reinforcement  materials  which,  although  they  do
ot  act  on  the  ischaemic  cause  of  ﬁstulae,  in  theory  might
educe  the  risk  of  mechanical  failure.18 Baltasar  et  al.,19
ike  our  group,  protect  the  section  line  with  a  continuous
ero-serous  suture  that  inverts  the  staples,  controls  bleed-
ng  and  attempts  to  reduce  the  number  of  leaks,  without
ncreasing  the  operation  costs  (Fig.  2).  They  have  recently
escribed  their  technique  using  an  omental  patch  together
ith  invagination,  the  idea  being  to  reduce  the  number  of
eaks  and  improve  stability  and  emptying  by  reducing  the
artial  torsion  that  some  residual  tubes  suffer.20
In  all  cases,  the  3  ﬁstulae  presented  by  the  patients  in
ur  study  occurred  after  discharge  from  hospital  (after  72  h)
nd  therefore  mechanical  failure  can  be  ruled  out  as  the
ause.  The  3  cases  presented  symptoms  of  fever  and  dysp-
oea,  and  no  case  presented  abdominal  pain.  Therefore,  we
hould  consider,  that  patients  who  attend  after  discharge
rom  hospital  with  fever  or  dyspnoea  in  the  postoperative
eriod  after  laparoscopic  sleeve  gastrectomy,  might  have
 ﬁstula  and  emergency  computed  tomography  should  be
erformed.  With  the  advent  of  the  new  endocutters  with
ri-staple  technology,  the  amount  of  ﬁstulae  appears  to  have
ecreased.  In  fact,  they  have  not  presented  at  all  since  weThroughout  our  series,  the  total  rate  of  complications
as  6.85%,  lower  than  the  17%  reported  in  other  series.21
owever,  it  was  similar  to  that  of  a  long  Spanish  multi-centre
3c
a
f
a
i
b
B
l
o
t
w
t
B
p
c
s
w
b
t
a
o
a
i
p
s
h
t
a
d
s
w
a
o
ﬁ
1
w
V
1
I
s
a
b
l
c
o
m
t
i
I
c
p
s
s
t
n
a
s
m
u
E
P
d
a
C
d
R
d
C
T
R
1
1
174  
ohort  which  included  540  patients  and  that  which  was
ccepted  in  a  consensus  document  of  the  American  Society
or  Metabolic  and  Bariatric  Surgery.7,22 These  complications
ppeared  during  the  ﬁrst  25  learning  curve  interventions,  all
n  females,  and  only  one  of  the  ﬁstulae  and  postoperative
leeding  presented  in  superobese  patients.
Deitel  and  Greeinstein23 propose  the  use  of  the  excess
MI  loss  percentage  to  evaluate  outcomes,  so  that  an  excel-
ent  outcome  would  be  if  it  were  in  excess  of  65%,  a good
utcome  if  it  were  between  50%  and  65%,  and  failure  if  less
han  50%.  In  our  series,  the  mean  excess  BMI  loss  percentage
as  67.92%,  in  line  with  the  data  in  the  literature.7,24,25 Fur-
hermore,  it  is  important  to  highlight  that  the  reduction  in
MI,  in  the  excess  BMI  loss  percentage  and  in  the  weight  loss
ercentage  were  not  dependent  on  the  time  in  the  learning
urve  of  our  series.
There  are  still  many  points  of  controversy  in  laparoscopic
leeve  gastrectomy  which  create  a  range  of  possibilities  on
hich  there  is  no  consensus,26 such  as  (a)  the  size  of  the
ougie  used  as  a  calibrator,  (b)  the  distance  from  the  pylorus
o  the  ﬁrst  section  line,  (c)  reinforcement  of  the  staple  line,
nd  (d)  the  routine  use  of  intraoperative  leak  testing,  all
f  these  are  issues  that  are  the  subject  of  constant  debate
mongst  the  authors  of  other  series  and  should  be  assessed
n  randomised  prospective  studies.
A  large  percentage  of  the  patients  of  this  study
resented  comorbidities.  Diabetes  mellitus,  high  blood  pres-
ure,  dyslipidaemia,  obstructive  sleep  apnoea  syndrome,
ypoventilation-obesity  syndrome  and  osteoarthritis  remit-
ed  in  at  least  70%,  and  the  case  of  obstructive  sleep
pnoea  syndrome  and  hypoventilation-obesity  syndrome
isappeared  entirely.  This  demonstrates  that  laparoscopic
leeve  gastrectomy  is  a  technique  which  not  only  inﬂuences
eight  loss  but  also  improves  complications.27--29 The  mech-
nisms  responsible  for  this  association  are  outside  the  scope
f  this  study.
With  regard  to  the  mean  transit  volumes  taken  after  the
rst  month  and  at  12  months  after  the  operation,  69.46  and
17.58  cm3 respectively,  statistically  signiﬁcant  differences
ere  observed  both  at  a  general  patient  level  and  by  sex.
idal  et  al.30 give  mean  volumes  both  at  one  month  and  at
2  months  that  are  similar  to  those  we  present  in  our  study.
t  is  true  that  despite  increasing  the  volume  of  the  gastric
leeve,  the  patients  continued  to  maintain  their  weight  loss
t  their  check  one  year  later.  Long-term  follow-up  would
e  helpful  in  order  to  evaluate  both  the  patients’  weight
oss  and  the  proportional  increase  in  gastric  volume,  and  to
onﬁrm  whether  this  equation  continues  to  be  maintained
r  whether,  by  contrast,  these  ﬁgures  come  to  a  halt  or,  even
ight  facilitate  further  weight  gain.
To  conclude,  laparoscopic  sleeve  gastrectomy  is  an  effec-
ive  and  safe  technique  for  the  treatment  of  morbid  obesity
n  reference  centres  with  experience  in  bariatric  surgery.
t  is  also  associated  with  a  signiﬁcant  remission  of  the
omorbidities  associated  with  morbid  obesity,  although  the
athophysiological  mechanism  is  not  completely  under-
tood.
The  fact  that  it  has  been  considered  erroneously  to  be  a
imple  procedure  has  encouraged  a  large  number  of  surgeons
o  perform  laparoscopic  sleeve  gastrectomy.  However,  it  is
ot  free  from  complications  that  present  in  a  low  percentage
nd  are  dependent  on  the  learning  curve.
1J.J.  García-Díaz  et  al.
If  these  ﬁndings  were  to  be  conﬁrmed  in  longer  patient
eries,  laparoscopic  sleeve  gastrectomy  would  be  the  treat-
ent  of  choice  for  morbid  obesity  and  should  preferably  be
ndertaken  in  reference  centres.
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